Alprolix (recombinant Factor IX Fc fusion protein): Extended half-life product for the prophylaxis and treatment of hemophilia B

Jonathan M Ducore, Maricel G. Miguelino, Jerry S Powell

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint Dive into the research topics of 'Alprolix (recombinant Factor IX Fc fusion protein): Extended half-life product for the prophylaxis and treatment of hemophilia B'. Together they form a unique fingerprint.

Medicine & Life Sciences